Cancer Drug Costs

[Hopeful]

What I appreciated was the cancer docs finally digging in and saying, "No Mas!" Especially when it shows that the approach works in getting the costs reduced. The disappointment was the observation that developing drugs that only provide incremental additional survival in combination with older drugs has become the business model. If we are paying all this money to justify the drug companies' r&d costs, we should expect them to swing for the fences at least part of the time, instead of constantly bunting.

Hopeful